Sonali Panchal

• Lead marketing strategy for Prothiaden, managing a ₹100 Cr portfolio and strengthening brand positioning.
• Track performance against 97% sales targets while maintaining disciplined execution of HO plans.
• Maintain 100% execution of HO plans to support portfolio growth, profitability, and operational consistency.
• Advance Prothiaden to the 2nd largest antidepressant brand, and improving market ranking by one position.
• Conduct in-depth market research through advisory board meetings and HCP immersion programs to identify growth opportunities across psychiatry, neurology, and consulting physician specialties.
• Design and implement sales force training programs that strengthen scientific communication, customer engagement, and in-clinic effectiveness.
• Create and activate the "Bring Back the Smile" in-clinic campaign to build awareness of anxiety linked to chronic conditions.

• Directing the marketing strategy for the Sporlac brand, managing a 140 Cr portfolio and positioning it as the 4th leading brand in the probiotic market.
• Conducting in-depth market research to uncover growth opportunities and expanding brand reach across key specialties such as Pediatricians, Gynecologists, IVF Specialists, Consulting Physicians, and Nephrologists.
• Launching new product line extensions within the Sporlac franchise, contributing to substantial portfolio growth.
• Executing targeted social media campaigns and strategic geographic expansions to solidify market presence in underrepresented regions.
• Designing and implementing effective training programs to enhance sales force communication and improve in-clinic effectiveness.
• Spearheading the "Diarrhea Free Monsoon Campaign" in collaboration with 40+ KOLs, boosting brand advocacy and increasing customer loyalty.
• Consistently achieving 100% sales targets, maintaining EBITDA of 102%, and managing divisional budgets and productivity metrics.
  

Key Highlights:

• Received accolades for innovative marketing strategies that led to an 24% increase in product Rxns and sales within targeted demographics.
• Recognized for innovative marketing strategies that led to a 18% increase in Rxn within the pediatric probiotic segment, underscoring a deep understanding of market dynamics.

• Managed the Azithral portfolio, worth over 450 Cr, successfully leading its strategic growth to maintain its position as the most prescribed antibiotic liquid in the pediatric segment
• Developed and implemented educational programs and academic workshops that enhanced engagement with healthcare professionals, fostering brand loyalty
• Collaborated with sales teams to ensure seamless execution of campaigns and alignment with strategic market goals
• Conducted thorough competitive and market trend analyses, identifying key opportunities to preserve market leadership
• Led the marketing strategy for key brands such as PEGTEARS, Moxoft, and Moxoft LP, creating tailored communication strategies for optimal market penetration
• Established PEGTEARS in the LASIK domain through innovative messaging and strategic clinical positioning.
• Recommended and implemented key formulation changes to enhance product relevance and boost competitiveness in the market.
• Partnered with the sales team to drive strategy execution and maximize prescription growth

Key Highlights:

• Successfully implemented innovative marketing strategies that resulted in maintaining No.1 prescribed brand within the pediatric antibiotic segment by Pediatricians for consecutive
  7.5 years.